Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith T Flaherty

Showing results (411-420 of 418) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 418 results.
The New England Journal of Medicine|January 20, 2012
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitorsFei Su, Amaya Viros, Carla Milagre, et al.
Cell Reports|November 16, 2017
A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of MelanomaClemens Krepler, Katrin Sproesser, Patricia Brafford, et al.
Cell Reports. Medicine|March 31, 2026
A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanomaShiyou Wei, Yulan Deng, Jinho Lee, et al.
Cell|November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.
Cell Reports. Medicine|June 27, 2025
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explantsOr-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Nature|January 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapyYi Sun, Or-Yam Revach, Seth Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2025
A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical TrialLinda K Zane, Laura M Yee, Ting-Chia Chang, et al.
Cancer Discovery|November 5, 2017
<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W Jenkins, Amir R Aref, Patrick H Lizotte, et al.
Pageof 42

Showing results (411-420 of 418) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 418 results.
The New England Journal of Medicine|January 20, 2012
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitorsFei Su, Amaya Viros, Carla Milagre, et al.
Cell Reports|November 16, 2017
A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of MelanomaClemens Krepler, Katrin Sproesser, Patricia Brafford, et al.
Cell Reports. Medicine|March 31, 2026
A longitudinal, multi-omic atlas reveals the emergence of a spatially organized immunosuppressive ecosystem in resistant melanomaShiyou Wei, Yulan Deng, Jinho Lee, et al.
Cell|November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.
Cell Reports. Medicine|June 27, 2025
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explantsOr-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Nature|January 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapyYi Sun, Or-Yam Revach, Seth Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2025
A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical TrialLinda K Zane, Laura M Yee, Ting-Chia Chang, et al.
Cancer Discovery|November 5, 2017
<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W Jenkins, Amir R Aref, Patrick H Lizotte, et al.
Pageof 42